Kestra Advisory Services’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-474
Closed -$228K 3324
2026
Q1
$228K Sell
474
-611
-56% -$313K ﹤0.01% 2850
2025
Q4
$609K Buy
1,085
+332
+44% +$188K ﹤0.01% 2000
2025
Q3
$387K Sell
753
-28
-4% -$12.2K ﹤0.01% 2246
2025
Q2
$245K Buy
781
+3
+0.4% +$901 ﹤0.01% 2518
2025
Q1
$237K Sell
778
-1,531
-66% -$515K ﹤0.01% 2354
2024
Q4
$767K Buy
2,309
+218
+10% +$73.9K ﹤0.01% 1569
2024
Q3
$698K Buy
2,091
+1,164
+126% +$442K ﹤0.01% 1545
2024
Q2
$382K Buy
927
+161
+21% +$63.8K ﹤0.01% 1963
2024
Q1
$310K Buy
+766
New +$269K ﹤0.01% 1975

Other funds holding MEDP

Kestra Advisory Services's MEDP Position: Q2 2026 in Review

Kestra Advisory Services sold out of Medpace (MEDP) in Q2 2026, closing a stake of 474 shares — an estimated $228K sold.

Kestra Advisory Services first reported a position in MEDP in Q1 2024 and held it in 9 quarters. The position peaked at $767K in Q4 2024. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Kestra Advisory Services reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 474 Medpace shares in Q2 2026, an estimated $228K.
  • Kestra Advisory Services first reported a position in Medpace in Q1 2024 and held it in 9 quarters.
  • Kestra Advisory Services's Medpace position peaked at $767K in Q4 2024.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.